Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Purchase, New York, focused on the discovery and development of small-molecule therapeutics targeting age-related neurodegenerative diseases of the central nervous system and retina. The company trades on NASDAQ under the ticker CGTX.